scholarly article | Q13442814 |
P50 | author | Barthelmes Daniel | Q89411800 |
P2093 | author name string | Grimm Christian | |
Schori Christian | |||
Zygoula Ioanna | |||
P2860 | cites work | Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization | Q24301539 |
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension | Q24307473 | ||
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia | Q24315006 | ||
Ranibizumab and bevacizumab for neovascular age-related macular degeneration | Q24616209 | ||
PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases | Q27026916 | ||
Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. | Q54564766 | ||
TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population | Q57243541 | ||
Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | Q67660771 | ||
Prevalence of age-related maculopathy. The Beaver Dam Eye Study | Q68207448 | ||
Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages | Q71078185 | ||
Hypoxic regulation of vascular endothelial growth factor in retinal cells | Q71559437 | ||
Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group | Q72093526 | ||
The prevalence of age-related maculopathy in the Rotterdam Study | Q72560755 | ||
Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio | Q73501230 | ||
Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy | Q74708785 | ||
Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus | Q78040840 | ||
Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy | Q79527689 | ||
Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization | Q79755485 | ||
Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy | Q81473347 | ||
Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization | Q82613057 | ||
Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy | Q83625730 | ||
Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy | Q84378690 | ||
Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy | Q84740925 | ||
Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab | Q85062432 | ||
PEDF and VEGF plasma level alterations in patients with dry form of age-related degeneration--a possible link to the development of the disease | Q85948537 | ||
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis | Q28139159 | ||
Complement factor H variant increases the risk of age-related macular degeneration | Q28239239 | ||
Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation | Q28252467 | ||
Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy | Q28257133 | ||
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy | Q28262797 | ||
Leukocyte-mediated endothelial cell injury and death in the diabetic retina | Q28345653 | ||
Hypoxia-induced upregulation of pigment epithelium-derived factor by retinal glial (Müller) cells | Q28572018 | ||
Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. | Q30885363 | ||
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization | Q31147566 | ||
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization | Q31877730 | ||
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade | Q33209039 | ||
Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study | Q33709631 | ||
Epigenetic control of hypoxia inducible factor-1α-dependent expression of placental growth factor in hypoxic conditions. | Q34000432 | ||
Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. | Q34062411 | ||
HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration | Q34133712 | ||
Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy | Q34263212 | ||
Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy | Q34352379 | ||
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. | Q34652928 | ||
Vascular endothelial growth factors and angiogenesis in eye disease | Q35070749 | ||
Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients | Q35201511 | ||
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation | Q35761464 | ||
Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease | Q35844023 | ||
Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts | Q36052279 | ||
Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases | Q36213861 | ||
Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy | Q36490463 | ||
Relationship between RPE and choriocapillaris in age-related macular degeneration | Q36791715 | ||
A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients | Q36948659 | ||
Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. | Q37157321 | ||
Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration. | Q37626349 | ||
Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression | Q38329502 | ||
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study | Q39442873 | ||
Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients | Q39708445 | ||
Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro | Q41869840 | ||
Increased expression of angiogenic growth factors in age-related maculopathy | Q43095714 | ||
PlGF, immune system and hypertension | Q43200805 | ||
Increased prevalence of microthromboses in retinal capillaries of diabetic individuals | Q43618953 | ||
A specific in vitro bioassay for measuring erythropoietin levels in human serum and plasma | Q43730987 | ||
Serum and plasma levels of FGF-2 and VEGF in healthy blood donors | Q44292265 | ||
AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat. | Q44295605 | ||
The role of insulin-like growth factor I and hypoxia inducible factor 1α in vascular endothelial growth factor expression in type 2 diabetes | Q44546064 | ||
The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients | Q44887069 | ||
Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism. | Q45264621 | ||
Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy | Q46667958 | ||
Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization | Q46937245 | ||
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study | Q46948681 | ||
Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia | Q47674689 | ||
Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes. | Q51346909 | ||
Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study. | Q51368843 | ||
Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy. | Q53115047 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ggplot2 | Q326489 |
P433 | issue | 2 | |
P304 | page(s) | 325-332 | |
P577 | publication date | 2017-11-25 | |
P1433 | published in | Graefe's Archive for Clinical and Experimental Ophthalmology | Q15757667 |
P1476 | title | Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration | |
P478 | volume | 256 |
Search more.